22261-99-0 Usage
Uses
Used in Pharmaceutical Industry:
Propanamide, N-(1-methyl-4-piperidinyl)-N-phenyl-, is used as a pharmaceutical compound for its potential therapeutic properties. The expression is: Propanamide, N-(1-methyl-4-piperidinyl)-N-phenylis used as a therapeutic agent for its potential to modulate various biological pathways and exhibit pharmacological effects.
Used in Chemical Research:
In the field of chemical research, Propanamide, N-(1-methyl-4-piperidinyl)-N-phenyl-, is used as a research compound for studying its chemical properties, reactivity, and potential applications in the synthesis of other bioactive molecules. The expression is: Propanamide, N-(1-methyl-4-piperidinyl)-N-phenylis used as a research compound for understanding its chemical behavior and exploring its potential in the development of new drugs and materials.
Used in Drug Delivery Systems:
Propanamide, N-(1-methyl-4-piperidinyl)-N-phenyl-, may also be utilized in the development of drug delivery systems, where it could serve as a carrier or enhancer for other therapeutic agents. The expression is: Propanamide, N-(1-methyl-4-piperidinyl)-N-phenylis used as a component in drug delivery systems for its potential to improve the delivery, bioavailability, and therapeutic outcomes of other pharmaceutical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 22261-99-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,2,6 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 22261-99:
(7*2)+(6*2)+(5*2)+(4*6)+(3*1)+(2*9)+(1*9)=90
90 % 10 = 0
So 22261-99-0 is a valid CAS Registry Number.
22261-99-0Relevant academic research and scientific papers
Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs
-
, (2008/06/13)
The invention provides an immunogen comprising a hapten coupled to an antigenicity-conferring carrier material, a conjugate comprising the aforementioned hapten coupled to a labelling agent, as well as, antibodies raised against the aforementioned immunogen and capable of binding with at least one structural epitope of metabolites of fentanyl and of metabolites of fentanyl analogs.
